Related Experiment Video
Updated: Oct 7, 2025
08:49
Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
Published on: May 27, 2016
11.3K
Circulating microvesicles and exosomes in small cell lung cancer by quantitative proteomics
Shona Pedersen1, Katrine Papendick Jensen2,3, Bent Honoré2,4
1Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar University, 2713, Doha, Qatar. spedersen@qu.edu.qa.
Clinical Proteomics
|January 8, 2022
Summary
This study identified novel protein markers in extracellular vesicles for early detection of small cell lung cancer (SCLC). These findings offer potential for developing non-invasive diagnostic tools for SCLC.
Area of Science:
- Oncology
- Proteomics
- Biomarker Discovery
Background:
- Early detection of small cell lung cancer (SCLC) requires reliable biomarkers.
- Extracellular vesicles (EVs) contain tumor-specific proteins, making them promising for cancer marker discovery.
- Quantitative proteomic profiling of circulating EVs offers a high-throughput platform for identifying novel SCLC markers.
Purpose of the Study:
- To investigate the proteome dynamics of plasma-derived microvesicles and exosomes in newly diagnosed SCLC patients.
- To identify potential protein markers for improving early SCLC detection.
Main Methods:
- Isolated plasma-derived microvesicles and exosomes from 24 SCLC patients and 24 healthy controls.
- Quantified EV proteins using label-free mass spectrometry.
- Performed statistical analysis and functional enrichment to identify differentially expressed proteins and implicated pathways.
Main Results:
- Identified 10 common and 16-17 unique proteins in EVs between SCLC patients and controls.
- Found dysregulation of coagulation factor XIII A and complement factor H-related protein 4.
- Suggested a potential tumor-suppressing role of blood coagulation and involvement of complement activation in SCLC.
Conclusions:
- Identified several differentially expressed proteins in circulating EVs between SCLC patients and healthy individuals.
- This is the first study demonstrating potential diagnostic attributes of EV proteins for SCLC.
- These findings open new avenues for novel non-invasive SCLC biomarkers.
